Meridian’s DuoDote autoinjectors will be manufactured at the Missouri-based facility of Meridian's parent company Kindeva ...
NAAK: The nerve agent antidote kit (NAAK) Mark I is a dual-chamber autoinjector kit that administers atropine and pralidoxime when used. These kits were created to be self-administered by individual ...
The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.
expand Meridian Medical Technologies' DuoDote is an U.S. Federal Drug Administration-approved autoinjector that delivers atropine and pralidoxime chloride as a chemical nerve agent antidote.